120 related articles for article (PubMed ID: 8280369)
21. GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.
Burghardt B; Wenger C; Barabás K; Rácz G; Oláh A; Flautner L; Coy DH; Gress TM; Varga G
Peptides; 2001 Jul; 22(7):1119-28. PubMed ID: 11445243
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
23. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.
Staley J; Coy DH; Jensen RT; Moody TW
J Mol Neurosci; 1993; 4(1):29-40. PubMed ID: 8391295
[TBL] [Abstract][Full Text] [Related]
24. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
[TBL] [Abstract][Full Text] [Related]
25. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
[TBL] [Abstract][Full Text] [Related]
26. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
27. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
28. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor.
Langer DA; Kautzman D; Kane MA
Lung Cancer; 2002 Jun; 36(3):235-42. PubMed ID: 12009231
[TBL] [Abstract][Full Text] [Related]
30. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
[TBL] [Abstract][Full Text] [Related]
31. [The role of gastrin releasing peptide as a lung growth factor].
Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
[TBL] [Abstract][Full Text] [Related]
32. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
Jungwirth A; Galvan G; Pinski J; Halmos G; Szepeshazi K; Cai RZ; Groot K; Schally AV
Prostate; 1997 Aug; 32(3):164-72. PubMed ID: 9254895
[TBL] [Abstract][Full Text] [Related]
33. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
34. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
Koppán M; Halmos G; Arencibia JM; Lamharzi N; Schally AV
Cancer; 1998 Oct; 83(7):1335-43. PubMed ID: 9762934
[TBL] [Abstract][Full Text] [Related]
35. Bombesin stimulates growth of human prostatic cancer cells in vitro.
Bologna M; Festuccia C; Muzi P; Biordi L; Ciomei M
Cancer; 1989 May; 63(9):1714-20. PubMed ID: 2539244
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
[TBL] [Abstract][Full Text] [Related]
37. The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues.
Garcia LJ; Pradhan TK; Weber HC; Moody TW; Jensen RT
Biochim Biophys Acta; 1997 May; 1356(3):343-54. PubMed ID: 9194577
[TBL] [Abstract][Full Text] [Related]
38. A rhesus monkey model to characterize the role of gastrin-releasing peptide (GRP) in lung development. Evidence for stimulation of airway growth.
Li K; Nagalla SR; Spindel ER
J Clin Invest; 1994 Oct; 94(4):1605-15. PubMed ID: 7929836
[TBL] [Abstract][Full Text] [Related]
39. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
Terashima H; Debas HT; Bunnett NW
Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
[TBL] [Abstract][Full Text] [Related]
40. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
